Merck KGaA (OTCMKTS:MKGAF) Hits New 12-Month Low – Should You Sell?

Merck KGaA (OTCMKTS:MKGAF) reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $140.01 and last traded at $146.54, with a volume of 1464 shares trading hands. The stock had previously closed at $141.90.

Wall Street Analyst Weigh In

Separately, The Goldman Sachs Group raised Merck KGaA to a “strong-buy” rating in a research note on Thursday, September 19th.

Merck KGaA Trading Up 0.5 %

The stock’s fifty day moving average price is $153.50 and its 200 day moving average price is $169.18. The stock has a market cap of $19.03 billion, a P/E ratio of 22.48 and a beta of 0.96. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27.

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.